Financials data is unavailable for this security.
Cash flow in CNYView more
In 2024, cash reserves at KeyMed Biosciences Inc fell by 432.62m. Cash Flow from Financing totalled 283.90m or 66.31% of revenues. In addition the company used 789.63m for operations while cash from investing totalled 67.71m.
| Cash flow per share | -0.6931 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | 12.10 |
|---|---|
| Tangible book value per share | 12.07 |
More ▼
Balance sheet in CNYView more
| Current ratio | 3.95 |
|---|---|
| Quick ratio | 3.74 |
| Total debt/total equity | 0.273 |
|---|---|
| Total debt/total capital | 0.2145 |
More ▼
